Unilife Corp  

(Public, NASDAQ:UNIS)   Watch this stock  
Find more results for UNIS
3.93
+0.14 (3.69%)
Mar 4 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.69 - 3.93
52 week 2.00 - 5.80
Open 3.79
Vol / Avg. 0.00/1.97M
Mkt cap 492.04M
P/E     -
Div/yield     -
EPS -0.69
Shares 128.83M
Beta 0.97
Inst. own 36%
May 11, 2015
Q3 2015 Unilife Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Feb 12, 2015
Unilife Corp at Leerink Global Healthcare Conference
Feb 9, 2015
Q2 2015 Unilife Corp Earnings Call - Webcast
Feb 9, 2015
Q2 2015 Unilife Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -358.82% -394.17%
Operating margin -308.48% -349.89%
EBITD margin - -322.12%
Return on average assets -93.03% -77.11%
Return on average equity - -277.50%
Employees 209 -
CDP Score - -

Address

250 Cross Farm Lane
YORK, PA 17406
United States - Map
+1-717-3843400 (Phone)
+1-717-3843401 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Unilife Corporation, is a drug delivery company. The Company has product platforms, including pre-filled syringes, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and other novel injectable drug delivery systems. The Company�s product platform includes: Pre-filled Syringes, Wearable Injectors, Auto-Injectors, Drug Reconstitution Delivery Systems, and Ocular Delivery Systems. Pre-filled Syringes, offers a single-chamber pre-filled syringe, Unifill. Wearable Injectors, offers pre-filled and disposable devices, ReadyToGo. Auto-Injectors, offers disposable and reusable auto-injectors, LISA and RITA. Drug Reconstitution Delivery Systems, offers dual-chamber pre-filled syringes, EZMix. Ocular Delivery Systems, offers localized and targeted delivery of ophthalmic therapies.

Officers and directors

Alan D. Shortall Chairman of the Board, Chief Executive Officer
Age: 61
Bio & Compensation  - Reuters
Ramin Mojdehbakhsh Ph.D. President, Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
Slavko James Joseph Bosnjak Deputy Vice Chairman, Lead independent Director
Age: 65
Bio & Compensation  - Reuters
David C. Hastings Chief Financial Officer
Age: 53
Bio & Compensation  - Reuters
John Ryan J.D. Senior Vice President, General Counsel, Secretary
Age: 44
Bio & Compensation  - Reuters
Dennis P. Pyers Senior Vice President, Controller
Age: 53
Bio & Compensation  - Reuters
Kevin Sellers Senior Vice President - Marketing and Communications
Bio & Compensation  - Reuters
Mark V. Iampietro Vice President - Quality and Regulatory Affairs
Age: 61
Bio & Compensation  - Reuters
Jeff Carter Non-Executive Director
Age: 56
Bio & Compensation  - Reuters
William Galle Independent Non-Executive Director
Age: 75
Bio & Compensation  - Reuters